{
  "id": "120m-partnership-brings-ai-to-cardiometabolic-therapy",
  "title": "$120m partnership brings AI to cardiometabolic therapy",
  "summary": "Insilico Medicine and Qilu Pharmaceutical team up to fast-track AI-designed drugs tackling heart, metabolism and aging-related diseases. Imagine a world where the medicines for heart disease, diabetes or obesity aren’t just discovered after years of trial and error, but are designed by artificial intelligence, tested faster and tailored to work better. That world is inching […] The post $120m partnership brings AI to cardiometabolic therapy appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/120m-partnership-brings-ai-to-cardiometabolic-therapy/",
  "source": "Longevity.Technology",
  "author": "Kyle Umipig",
  "category": "news",
  "publishedAt": "2026-01-28T14:07:29.000Z",
  "fetchedAt": "2026-02-04T10:49:05.821Z",
  "relevanceScore": 0.4,
  "matchedKeywords": [
    "longevity",
    "aging"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.868Z"
}